Can be around 1.30 level as based on the production figure, nxt qr result might not be good.

Dead cat bounce

看JT的走势，不可能没庄。
说不定还有超过一个庄.

if you look closely, every segment of BCorp is already generating profits.
just that the high borrowings resulting an extreme amount of interest (~RM200m per quarter) is eating away a huge chunk of profits.
Or else BCorp would be a wonderful company!

aceso are you sure they are allowed to resume 'certain' areas without a license from the authority?
which 'certain' area then may i ask?

bonescythe 期待你与我们分享你的投资概念...

你有去看看2015和2016年报的语气差别吗？

2015.
Operations Review
To curtail this, the Group plans to apply several transformation activities to vary its revenue, augment
profitability, maintain growth and enhance efficiency. Steps to be taken would include recognising possible
new ventures and opportunities, expanding ICT into new sectors, establishing new lines of business such
as leisure, property development, and gaming and entertainment, as well as optimising revenue mix. One
measure already in place include reorganizing the Group’s operating structure.


Prospects
The Group’s strategy is to diversify its business to include complementary commercial endeavours in areas
such as gaming, property and leisure. The Group plans to introduce new revenue channels while refining its
core businesses of ICT Solutions & Services and Payment Solutions & Services.
The Group is fully aware of the ever changing and thought-provoking business outlook and is feverishly striving
to mend its performance.

2016

Operations Review
As part of the transformation activities, the Group will
continue to explore new business opportunities to
strengthen its revenue stream and performance. Steps
to be taken would include recognising possible new
ventures and opportunities, expanding ICT into new
sectors, and seeking new clients to optimise revenue
mix.


Prospects
The Group’s business environment is expected to remain
challenging for 2016 due to uncertainties in regional
economic outlook. We do not anticipate government
spending to rebound and there will be lesser ICT
business opportunities on the local front. In view of
this, the Group will implement relevant strategies to
overcome the challenges such as to concentrate instead
on non-government entities, and to also continue
to focus on various cost control exercises to contain
overheads and improve operational processes to achieve
greater efficiency and productivity.

好吧，祝你好运，也祝你早日解套。

http://bonescythe.blogspot.my/2015/11/dataprep-genting-of-china.html

http://bonescythe.blogspot.my/2015/02/february-focus-dataprep-wild-card.html

觉得RH的分析比较有道理。
这文章有提到任何值得买入（所谓赌场计划）的facts吗？
use facts, not rumours to convince others.
你可以看看最新QR，管理层prospect只提到营业额和净利会下跌，没提到传闻的赌场计划。

不多说了，多说也是无谓。
10/1/2017 RM0.225 Peg DATAPRP，且看一年后结果如何。
在这个价位买进的智者会不会开番，不买的笨蛋会不会后悔。

Pharmaniaga case check the revenue percentage 1st only u compare.
Its total different case as you know who is behind pharmaniaga.

the impact will be very substantial if they are unable to get back the manufacturing license.
as all manufacturing process had been halted.

if managed to get back the license, probably suffer from revenue loss due to unable to manufacturing the products in the period when license revoked.

free trip to holland

Hovid Berhad (“Hovid”) wishes to announce that Hovid has received a letter from the Pharmaceutical Services Division of the Ministry of Health (“PSD”) on the revocation of our Manufacturing Licences (“Revocation”) via facsimile on 9 January 2017 at 8.58 a.m.



Arising from the audit conducted by National Pharmaceutical Regulatory Department (“NPRA”) on 5 January 2017, PSD issued the letter to revoke both the Manufacturing Licences for our facilities located at Lot 56442, 7 ½ Miles, Jalan Ipoh/Chemor 31200 Chemor Perak and Lot 121, Jalan Tunku Abdul Rahman (formerly Jalan Kuala Kangsar), 30010 Ipoh, Perak. Consequently, all our manufacturing activities are halted with immediate effect today. The revocation was based on the following audit findings:-



Current Good Manufacturing Practice (“cGMP”) compliance are not acceptable, and
Pharmaceutical Quality System does not comply with the latest cGMP requirements.

Hovid targets to revert with the necessary corrective actions to comply with cGMP required by NPRA by end of January 2017, and will invite the NPRA to audit our facilities and cGMP immediately thereafter. The re-issuance of the licences will be subject to NPRA being satisfied with the outcome of their audit.



However, our distribution subsidiaries in Malaysia, Hong Kong and the Philippines will continue to market and sell the existing stocks held by them respectively.



This announcement is dated 9 January 2017.

since we are human, making mistake is not a big issue.
making a mistake and doesn't admit it is an issue. (refuse to cut loss)

when we make any mistake, realize it (cut loss) and let it be a lesson for us.

compared to those holland sifu that issue holland call.

harry is way better, at least he did not issue any holland call.

i feel that he is quite conservative when comes to stock pick, he will not issue any buy call.
he is more of a reporter style.

all i can say is, his article not suitable for us.
but still, imagine the time when you are newbie and you meet person like harry, it would help.

John Lu Sampah
08/01/2017 10:47
----------------------

john, before you make any harsh comment.
look into the mirror first.
so far you not even run any blog in i3 at all, i.e 0 article.
what contribution had you done which entitled you to make such harsh comment?

this article isn't that useful for experienced investor, but it might mean something for new investor as to how to pick some companies related to our daily life.

long term wise not much impact.
short term might see some drawback

In a statement issued today, Health director-general Datuk Dr Noor Hisham Abdullah said this was because the batch contains boxes which label the tablets as Ternolol 50 on the outside packaging, while the label on the blister states them as Ternolol Tab 100mg instead

@vincent,
there are chances if someone is suffering from the side effects.

the medicine is all good, just that they package it wrongly.
the medicine is 10mg, but they package it as 5mg in the box and blister.
this mistake that cause the doubling of dose is not a small issue.

if they export the affected batch overseas.
but i don't think generic medicine have a market in developed countries like EU and US.

there will be financial impact other than impact on image.
its a very simple thing in QC to double check the strength of the drug yet they fail to do so.

Cost of the batch affected being recalled will be bear by the company.
Lucky they're in Malaysia, where the general awareness is low,if they are in country like US, consumer might as well as file a lawsuit against them.

Peter, of course they will not feel comfortable since its double the dose.
some might even leads to hypotension due to the higher than intended dose

not a good news for hovid

http://www.nst.com.my/news/2017/01/202171/health-authorities-issue-recall-ternolol-50-hypertension-tablets

1Q 17 definitely will not perform well as there is a RM9m expenses (loss) on disposal of properties.
And the weakness on RM vs USD doesn't look good for YKGI too.
Every 10% weakness in RM vs USD will see a RM12m losses for YKGI.
Maybe in the coming 1 year there is hedging done to protect against forex losses, but it does not work out well in the long run.

There's a lot of retailers that like to chase high instead of accumulating share at bottom.
This single factor had coz more than 90% of retailer making a loss.
Overcome this and it would increase your stake of outperform the benchmark.

But of course buy on weakness does not apply to those shares that drop a lot due to deteriorating fundamental like tekseng.

Management should not be an issue as the boss is sin chew's boss.
They control all malaysia chinese newspaper except kwong wah and oriental press.
Can check based on track record.

iii) point might be painful in short term but it MUST happen.

I have faith a 2 party system will benefit our country in the long run.
It's time for a change and a new breath from all negative elements bring by corrupt leadership.

steve,
The profit is not in the piggy bank.
Look at the borrowings of the company.

The management use (RM7M x 6) = RM42 million to buy so called "high-end residential property" in Damansara Heights last year which is totally not related to the business as a plantation company.

I just couldn't find any reason to justify to own of such "high-end residential property" last year.

retailer staying away is not necessarily a bad sign.
most retailers is those that buy high and sell low.

do you think retailer have the force to drive price in any direction?

and if you are a syndicate, before you push the price of any company, you would wish there having lots of or less retailers in it?

anyway, PRLEXUS is not suitable short term play due to uncertainties in US policy and the capex requirement for initial expansion.
Hold if for min 1 year to bear the fruits.

In the coming 1 or 2 yrs.
This company will enter an exciting growth phase.

The reason stock price is hammered down might be due to the likely abolishment of TPPA.
Trump is the factor, many scare he will implement import tax.
But on the other hand, consumer products price will increase a lot if he implement thoSe taxes or even when factory mpve their operation bck to usa, the overall cost will still be higher even with tax exemption, and he know he will only serve 1 term if this occur.

I am in the view that it's not possible and not feasible to move labour intensive industries such as clothing back to usa.
It's having a hard time to get enough labour force in malaysia and imagine what if it's in usa.

Hey Tan
Here's my stock pick 2017.
Thanks

SENDAI - 20%
PRLEXUS -30%
OCR - 20%
BJCORP - 20%
SMI - 10%

interest alone is scary...
RM200 million interest payment for every q.
RM800 million interest payment per year..
that's not healthy..

old news.....
they are reducing their stake everyday since months ago..
does it worth highlighting?

do you think SHELL will be at the price today if not EPF keep selling their stake?

from current value of warrant when mother is RM1.40.
RM0.20.

today is RM0.17 since mother 1.37.

"From now onwards, I will post all my writings on my own blog: koonyewyim.com. You are free to visit the site anytime."

hmm..i found this line quite familiar....
i think its the 2nd or not 3rd time we seeing this line in i3.

if mother drop to RM1.30, the warrant is worth only RM0.10.
which is a 50% drop in value, and the market price should be adjusted down by more than RM0.10.
and if mother RM1.20, warrant is worthless sheet of paper.


not sure how they value warrant,
not an expert of warrant as i don't usually buy any warrant.

my wild guess is they might be still holdings a huge chunk of warrants after exercising some of them, that's why they don't want the warrant price to dive down creating panic.
(or let them sell their warrant bit by bit everyday)

and if they are to exercise the warrant and followed by selling the shares in open market, it would be more sound to sell the warrant bit by bit everyday since there is a 35 sen premium.
earn 53 sen or 20 sen, its a no brainer. xD...
because when they sell the converted share open market, the drop in share price = more drop in warrant price.

anyway just a guess, only they know their plan.

if you believe in them...

Based on FELDA's logic,
"share price is not the accepted valuation method when it comes to a plantation company.
The share price may not reflect true value of EHP. The accepted valuation is enterprise value per hectare, which is US$16,000 enterprise value per hectare ev/ha)"

Since FELDA state US$16,000/ha is consider acceptable and reasonable.

Let's work on it.

US$16,000 x 4.5 x 69,589 ha
How much does the oil palm plantation of JTIASA worth?

RM 5 BILLION !

Market cap? RM1.3b

be careful dude even when you go to bank.
PI might disguise as bank officer...

Total shares issued: 68 Million.
1 day share traded: 57 Million.

What an achievement!!
You know someone is unloading.

R40s thanks for your analysis ... xD...
very informative & useful

业绩真的很好？？
业绩好还是不好，到底真正是亏钱还是赚钱，仔细看看QR再来评论不迟。
one off gain should not be accounted in.

if you are retailer, why will you exercise your warrant when the warrant is trading at a huge premium of RM0.34/warrant?

those exercise warrant must be big player where the open market is unable to take their warrant if they sell it.

Make a guess.
1 year from now, what would be the condition of this company?
By then their euro 4 and 5 refinery will be ready tp be running.
Seem like it might change name to HengYuan Refinery.
New website www.hrc.com.my

Q2 result will not be good as it's a traditionally low season.
So yeah its rational to say it will continue dropping.
But based on this kinda of vol and only 1 cent diff, we shall say not drop yet for the time being.
All is just some buy sell activity from retailer which can't drive the price in any direction.
Wait the big player movement 1st, as Prlexus hav many ut shareholders.
They will take you for a ride..

C'mon..just a 1 cent diff and u call it an accurate guess.
A share will either rise or fall anyway.
Guess u will not reply anything if the price remain or rising.